CFTR and cystic fibrosis: Finally, 42% of CF patients were treated with the modulator lumacaftor/ivacaftor (lumacaftor is a corrector molecule that stabilizes the CFTR protein maturation, and ivacaftor is a potentiator of the channel function) [23].